Parkside Financial Bank & Trust Supernus Pharmaceuticals, Inc. Transaction History

Parkside Financial Bank & Trust

$976 Million
Q3 2025

A detailed history of Parkside Financial Bank & Trust transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 308 shares of SUPN stock, worth $13,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308

Previous 34 805.88%

Holding current value

$13,860

Previous $1,000 1300.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$31.45 - $47.79 $8,617 - $13,094	274 Added 805.88%	308 $14,000
Q2 2025 Aug 06, 2025	BUY	$30.29 - $33.43 $575 - $635	19 Added 126.67%	34 $1,000
Q1 2025 May 08, 2025	BUY	$31.17 - $40.0 $467 - $600	15 New	15 $0
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $413 - $493	15 Added 8.93%	183 $5,000
Q2 2022 Jul 13, 2022	SELL	$25.33 - $34.25 $101 - $137	-4 Reduced 2.33%	168 $5,000

Q1 2022 May 13, 2022	BUY	$28.51 - $32.9 $114 - $131	4 Added 2.38%	172 $6,000
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $105 - $136	4 Added 2.44%	168 $5,000
Q3 2021 Oct 29, 2021	SELL	$23.54 - $31.39 $376 - $502	-16 Reduced 8.89%	164 $4,000
Q2 2021 Aug 06, 2021	BUY	$26.72 - $33.19 $427 - $531	16 Added 9.76%	180 $6,000
Q4 2020 Feb 09, 2021	BUY	$17.7 - $25.81 $2,407 - $3,510	136 Added 485.71%	164 $4,000
Q3 2020 Nov 06, 2020	SELL	$20.2 - $25.05 $323 - $400	-16 Reduced 36.36%	28 $1,000
Q2 2020 Aug 10, 2020	BUY	$17.09 - $24.89 $375 - $547	22 Added 100.0%	44 $1,000
Q1 2020 May 05, 2020	SELL	$14.45 - $24.69 $794 - $1,357	-55 Reduced 71.43%	22 $0
Q4 2019 Jan 30, 2020	BUY	$19.93 - $29.13 $577 - $844	29 Added 60.42%	77 $2,000
Q3 2019 Nov 05, 2019	BUY	$25.47 - $33.37 $1,222 - $1,601	48 New	48 $1,000
Q2 2019 Aug 06, 2019	SELL	$29.96 - $38.87 $1,617 - $2,098	-54 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$32.77 - $41.99 $360 - $461	11 Added 25.58%	54 $2,000
Q4 2018 Jan 31, 2019	BUY	$30.84 - $49.51 $277 - $445	9 Added 26.47%	43 $1,000
Q2 2018 Aug 03, 2018	BUY	$44.1 - $59.85 $132 - $179	3 Added 9.68%	34 $2,000
Q3 2017 Oct 27, 2017	BUY	$36.75 - $49.65 $1,139 - $1,539	31	31 $1,000

Others Institutions Holding SUPN

# of Institutions

330

Shares Held

60.2M

Call Options Held

234K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.41B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Account

Parkside Financial Bank & Trust Supernus Pharmaceuticals, Inc. Transaction History